Physician

Zeina Abdelnour Haddad, MD

According to 2025 Medicare claims, Zeina Haddad, MD (NPI: 1821251802) practices ophthalmology in the Pinehurst-Southern Pines, NC market, with the plurality of this provider's patient population coming from Moore, NC. This provider's primary affiliated billing organization is CAROLINA EYE ASSOCIATES INC (NPI: 1245211333; TIN: 56-1183309) and primary practice location at 28387-2927.

Haddad's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 805 traditional Medicare patients, billed 69,987 HCPCS/CPT codes, and received $3,138,554 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 657 prescription claims across 212 beneficiaries totaling $41,373 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 29 records totaling $960. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $450,523 to $3,138,554. Similarly, Part D prescription costs have risen steadily, from $11,435 to $41,373. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.1M2015 Medicare payment: $450,523 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,927,453 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,932,519 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,799,966 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,672,092 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,713,432 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,008,738 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,677,307 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,708,346 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,138,554 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153042,328$450,523
20167429,938$1,927,453
20178629,988$1,932,519
201896815,324$2,799,966
201999414,721$2,672,092
20201,03913,725$2,713,432
202199015,229$3,008,738
202280515,182$2,677,307
202377232,865$2,708,346
202480569,987$3,138,554

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$46K$91K2015 Drug cost: $11,435 (USD; Tot_Drug_Cst)2016 Drug cost: $16,304 (USD; Tot_Drug_Cst)2017 Drug cost: $15,728 (USD; Tot_Drug_Cst)2018 Drug cost: $28,645 (USD; Tot_Drug_Cst)2019 Drug cost: $46,713 (USD; Tot_Drug_Cst)2020 Drug cost: $42,477 (USD; Tot_Drug_Cst)2021 Drug cost: $82,799 (USD; Tot_Drug_Cst)2022 Drug cost: $91,037 (USD; Tot_Drug_Cst)2023 Drug cost: $49,742 (USD; Tot_Drug_Cst)2024 Drug cost: $41,373 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201561186$11,435
201675245$16,304
2017108348$15,728
2018157527$28,645
2019141456$46,713
2020158470$42,477
2021192522$82,799
2022194566$91,037
2023184627$49,742
2024212657$41,373

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3791,650$87
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more472590$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more455870$60
92134Imaging of retina7692,765$28
J2777Injection, faricimab-svoa, 0.1 mg22760,480$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1765,966$7,988
LumiganBimatoprost18492$5,124
Brimonidine TartrateBrimonidine Tartrate23887$2,531
SimbrinzaBrinzolamide/Brimonidine Tart11419$2,269
Ketorolac TromethamineKetorolac Tromethamine731,448$1,481

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.29$960Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Zeina Abdelnour Haddad, MD?

Tedicare shows public-source Medicare data for Zeina Abdelnour Haddad, MD (NPI 1821251802), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Zeina Abdelnour Haddad, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Zeina Abdelnour Haddad, MD?

Zeina Abdelnour Haddad, MD is linked to CAROLINA EYE ASSOCIATES INC (billing NPI 1245211333) in the available physician profile data.

Does Zeina Abdelnour Haddad, MD have Open Payments data?

Zeina Abdelnour Haddad, MD has 29 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.